1,402 Views
US Market Access Seminar
International
Christine Sarkisian, MA
Principal
Boston Business Acceleration
Angus McQuilken
Business Development Manager
McDermott Will & Emery LLP
Steve Miller
Senior Industry/Trade Policy Analyst
U.S. Department of Commerce
Mark Sullivan
Executive Director
Massachusetts Office of International Trade and Investment (MOITI)
Mike Graney
Vice President of Global Business Development
Charleston Regional Development Alliance
Kwame Ulmer
Principal
Ulmer Ventures
Vernessa Pollard
Partner and Co-Chair of FDA Practice
McDermott Will & Emery
Michael Ryan, JD
Partner
McDermott Will & Emery LLP
Jennifer Bock
Associate
McDermott Will & Emery LLP
Albert Sokol
Partner
McDermott Will & Emery LLP
U.S. Market Access Seminar
Sunday, September 22, 2019
12:30-5:00 p.m.
Boston Convention & Exhibition Center, Room 156C
Sponsored by: McDermott Will & Emery LLP
Please be aware that lunch will not be served.
This event is closed to the press.
The U.S. Market Access Seminar is a pre-program for international delegates attending The MedTech Conference. It will address key issues for non-U.S. medtech companies seeking to launch products in the U.S. market. Instructors will cover regulatory and reimbursement pathways as well as perspectives about the changing landscapes in each of these areas in the U.S.
Agenda
12:30-12:35 p.m. Welcome (Angus McQuilken, McDermott Will & Emery LLP)
12:35-1:05 p.m. U.S. Market Overview (Steve Miller, SelectUSA)
1:05-1:50 p.m. Establishing a Company in USA: Ramp-Up to Dealmaking and Operations
- Speakers: Jennifer Bock and Albert Sokol, McDermott, Will & Emery LLP
1:50-2:50 p.m. Establishing a Company in the U.S.: Economic Development Support
Moderator: Christine Sarkisian, Prinipal, Boston Business Acceleration
- Massachusetts (Mark Sullivan, MOITI)
- South Carolina (Mike Graney, Charleston Regional Development Alliance)
- California/Greater Los Angeles (Kwame Ulmer, Ulmer Ventures)
2:50-3:00 p.m. Break
3:00-5:00 p.m. Planning Your FDA and Reimbursement Pathways: How to Find Your Most Efficient Way to Market
This session, led by attorneys from McDermott Will & Emery’s FDA practice, will focus on the benefits of simultaneously considering FDA & reimbursement pathways when formulating product development plans, helping MedTech Conference attendees understand their most efficient path to market for new and novel devices, diagnostics and digital health technologies. U.S. companies, and international companies that are looking to sell products in the U.S., will benefit from being part of this interactive session.
- Speakers: Vernessa Pollard and Michael Ryan, Partners, McDermott, Will & Emery LLP
Delegates are invited to proceed to the International Reception, Legal Seafood Harbourside, 250 Northern Ave., Boston, from 5:30-7:30 p.m.
Reception sponsored by Québec